Available Clinical Trials

Clinical Research is an integral part of oncology at Bon Secours Richmond Health System. Clinical trials give patients access to the newest and best treatments for cancer. Bon Secours Richmond Health System is proud to provide the same options as leading national cancer centers. Whether it is looking at new surgical or radiation interventions, or giving a brand new medication, We are striving to find better ways to treat, prevent, and manage cancer.

To inquire about participation in a clinical trial, please contact us at (804) 893-8717.

Please see the available, in-progress clinical trials at Bon Secours Richmond Health System. You may filter these results by searching by disease type or keyword.

Search Clinical Trials

Select Category      or   

Displaying All Clinical Trials (21)
alliance-a011401
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuv...
alliance-a011502
Randomized Phase III Double Blinded Placebo Controlled Trial of Aspiri...
alliance-a021502
Randomized Trial of Standard Chemotherapy Alone or Combined with Atezo...
alliance-a031501
Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) in m...
alliance-a171601
A Phase II Trial Assessing the Tolerability of ...
alliance-alchemist-trials-a081105
Randomized Double Blind Placebo Controlled Study Of Erlotinib Or Place...
alliance-alchemist-trials-a151216
Receptor (EGFR) Mutant Non‐small Cell Lung Cancer (NSCLC)...
alliance-alchemist-trials-e4512
A Phase III Double‐Blind Trial for Surgically Resected Early Stage N...
alliance-alchemist-trials-ea5142
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)‐A Randomized Pha...
ea8153
Cabazitaxel with Abiraterone versus Abiraterone alone Randomized Trial...
ecog-acrin-eay131
NCI‐Molecular Analysis For Therapy Choice Program (NCI‐ MATCH)...
lung-map

Lung-MAP: Biomarker-Targeted Second-L...

merck-mk3475-756

A Randomized, Double-Blind, Phase III Study of Pembrol...

nrg-br004
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/...
nrg-oncology-nrg-br002
A Phase IIR/III Trial of Standard of Care Therapy with or without Ster...
nrg-oncology-nrg-br003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin...
nsabp-b-59
NSABP Foundation, Inc. / “A Randomized, Double-Blind, Phase ...
nsabp-fb-12
An Open-Label Phase II Trial to Evalua...
quilt-2-023
A Phase 2, Open-Label, Randomized Study of ALT-803, A Fusion Protein A...
quilt-3-055
A Phase IIb, Single-Arm, Open-Label Study of ALT-803 in Combination wi...
swog-s1418
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of M...

Showing 10 of 20